Toxoplasma gondii cathepsin C proteases (TgCPC1, 2, and 3) are important for the growth and survival of T. gondii. In the present study, B-cell and T-cell epitopes of TgCPC1 were predicted using DNAstar and the Immune Epitope Database. A TgCPC1 DNA vaccine was constructed, and its ability to induce protective immune responses against toxoplasmosis in BALB/c mice was evaluated in the presence or absence of the adjuvant α-GalCer. As results, TgCPC1 DNA vaccine with or without adjuvant α-GalCer showed higher levels of IgG and IgG2a in the serum, as well as IL-2 and IFN-γ in the spleen compared to controls (PBS, pEGFP-C1, and α-Galcer). Upon challenge infection with tachyzoites of T. gondii (RH), pCPC1/α-Galcer immunized mice showed the longest survival among all the groups. Mice vaccinated with DNA vaccine without adjuvant (pCPC1) showed better protective immunity compared to other controls (PBS, pEGFP-C1, and α-Galcer). These results indicate that a DNA vaccine encoding TgCPC1 is a potential vaccine candidate against toxoplasmosis.
Citations
Citations to this article as recorded by
Modest Protective Immune Responses Induced by a DNA Vaccine Expressing IMP1 of Toxoplasma gondii in BALB/c Mice Farid Alizadeh, Maryam Hataminejad, Hajar Yaghoobi, Hakim Azizi Parasite Immunology.2025;[Epub] CrossRef
Insight into the current
Toxoplasma gondii
DNA vaccine: a review article
Xirui Zhang, Hao Yuan, Yasser S. Mahmmod, Zipeng Yang, Mengpo Zhao, Yining Song, Shengjun Luo, Xiu-Xiang Zhang, Zi-Guo Yuan Expert Review of Vaccines.2023; 22(1): 66. CrossRef
iNKT cell agonists as vaccine adjuvants to combat infectious diseases Ya-Qian Li, Cheng Yan, Rui Luo, Zheng Liu Carbohydrate Research.2022; 513: 108527. CrossRef
Mining the Proteome of Toxoplasma Parasites Seeking Vaccine and Diagnostic Candidates Sajad Rashidi, Javier Sánchez-Montejo, Reza Mansouri, Mohammad Ali-Hassanzadeh, Amir Savardashtaki, Mohammad Saleh Bahreini, Mohammadreza Karimazar, Raúl Manzano-Román, Paul Nguewa Animals.2022; 12(9): 1098. CrossRef
A Novel Combined DNA Vaccine Encoding Toxoplasma gondii SAG1 and ROP18 Provokes Protective Immunity Against a Lethal Challenge in Mice Lamei Wu, Huijian Yang, Jianglin Wang, Xiuwen Yu, Yanhong He, Shenxia Chen Acta Parasitologica.2021; 66(4): 1387. CrossRef
Review of DNA Vaccine Approaches Against the Parasite Toxoplasma gondii Rosalie C. Warner, Ryan C. Chapman, Brianna N. Davis, Paul H. Davis Journal of Parasitology.2021;[Epub] CrossRef
Characterization of metalloproteases and serine proteases of Toxoplasma gondii tachyzoites and their effect on epithelial cells Carlos J. Ramírez-Flores, Rosalba Cruz-Mirón, Rossana Arroyo, Mónica E. Mondragón-Castelán, Tais Nopal-Guerrero, Sirenia González-Pozos, Emmanuel Ríos-Castro, Ricardo Mondragón-Flores Parasitology Research.2019; 118(1): 289. CrossRef
Antigenic Epitope Analysis and Efficacy Evaluation of GRA41 DNA Vaccine Against T. gondii Infection Jian Zhou, Chenxi Li, Yingquan Luo, Lin Wang Acta Parasitologica.2019; 64(3): 471. CrossRef
Cysteine proteases in protozoan parasites Jair L. Siqueira-Neto, Anjan Debnath, Laura-Isobel McCall, Jean A. Bernatchez, Momar Ndao, Sharon L. Reed, Philip J. Rosenthal, Photini Sinnis PLOS Neglected Tropical Diseases.2018; 12(8): e0006512. CrossRef
Immune Responses Induced by HSP60 DNA Vaccine against Toxoplasma gondii Infection in Kunming Mice Zhong-Yuan Li, Jing Lu, Nian-Zhang Zhang, Jia Chen, Xing-Quan Zhu The Korean Journal of Parasitology.2018; 56(3): 237. CrossRef
Evaluation of Protective Immune Response Induced by a DNA Vaccine Encoding GRA8 against Acute Toxoplasmosis in a Murine Model Jia-Qi Chu, Shuai Huang, Wei Ye, Xuan-Yan Fan, Rui Huang, Shi-Cai Ye, Cai-Yuan Yu, Wei-Yun Wu, Yu Zhou, Wei Zhou, Young-Ha Lee, Juan-Hua Quan The Korean Journal of Parasitology.2018; 56(4): 325. CrossRef
Toxoplasma gondii, an obligate intracellular protozoan parasite of the phylum Apicomplexa, can infect all warm-blooded vertebrates, including humans, livestock, and marine mammals. The aim of this study was to investigate whether superoxide dismutase (SOD) of T. gondii can be used as a new marker for genetic study or a potential vaccine candidate. The partial genome region of the SOD gene was amplified and sequenced from 10 different T. gondii isolates from different parts of the world, and all the sequences were examined by PCR-RFLP, sequence analysis, and phylogenetic reconstruction. The results showed that partial SOD gene sequences ranged from 1,702 bp to 1,712 bp and A + T contents varied from 50.1% to 51.1% among all examined isolates. Sequence alignment analysis identified total 43 variable nucleotide positions, and these results showed that 97.5% sequence similarity of SOD gene among all examined isolates. Phylogenetic analysis revealed that these SOD sequences were not an effective molecular marker for differential identification of T. gondii strains. The research demonstrated existence of low sequence variation in the SOD gene among T. gondii strains of different genotypes from different hosts and geographical regions.
Citations
Citations to this article as recorded by
Superoxide Dismutases in Immune Regulation and Infectious Diseases Tong Liu, Jiajin Shang, Qijun Chen Antioxidants.2025; 14(7): 809. CrossRef
Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice Yuan Liu, Aiping Cao, Yawen Li, Xun Li, Hua Cong, Shenyi He, Huaiyu Zhou BMC Infectious Diseases.2017;[Epub] CrossRef
First
Prev
